These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 36627181

  • 1. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Hatipoglu S, Gardezi SKM, Azzu A, Baksi J, Alpendurada F, Izgi C, Khattar R, Kouranos V, Wells AU, Sharma R, Wechalekar K, Pennell DJ, Mohiaddin R.
    Heart; 2023 Apr 25; 109(10):748-755. PubMed ID: 36627181
    [Abstract] [Full Text] [Related]

  • 2. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, Müller KAL, Castor T, Mahrholdt H, Häntschel M, Hetzel J, Dittmann H, Nikolaou K, Gawaz M, la Fougère C, Krumm P.
    JACC Cardiovasc Imaging; 2022 Mar 25; 15(3):445-456. PubMed ID: 34656480
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY, Carter SV, Flatley E, Ward RP, Moss JD, Appelbaum DE, Singh A, Lang RM, Tung R, Patel AR.
    Int J Cardiovasc Imaging; 2021 Apr 25; 37(4):1361-1369. PubMed ID: 33225427
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis.
    Okune M, Yasuda M, Soejima N, Kagioka Y, Kakehi K, Kawamura T, Hanaoka K, Kaida H, Ishii K, Nakazawa G, Miyazaki S, Iwanaga Y.
    J Nucl Cardiol; 2022 Apr 25; 29(2):753-764. PubMed ID: 33000410
    [Abstract] [Full Text] [Related]

  • 5. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S, Momose M, Fukushima K, Serizawa N, Suzuki A, Kondo C, Abe K, Sakai S, Hagiwara N.
    Ann Nucl Med; 2017 Feb 25; 31(2):135-143. PubMed ID: 27804054
    [Abstract] [Full Text] [Related]

  • 6. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.
    Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, Agrawal M, Madan R, Taqueti VR, Steigner M, Skali H, Kwong RY, Stewart GC, Dorbala S, Di Carli MF, Blankstein R.
    Circ Cardiovasc Imaging; 2018 Jan 25; 11(1):e007030. PubMed ID: 29335272
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/18F-fluorodeoxyglucose positron emission tomography examinations.
    Tanaka TD, Nagai T, Nagoshi T, Yoshimura M.
    J Nucl Cardiol; 2020 Dec 25; 27(6):2149-2153. PubMed ID: 31773564
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC, Menezes LJ, Barnes A, Mohiddin SA, Sekhri N, Porter JC, Booth HL, Garrett E, Patel RS, Pavlou M, Groves AM, Elliott PM.
    Eur Heart J Cardiovasc Imaging; 2018 Jul 01; 19(7):757-767. PubMed ID: 29319785
    [Abstract] [Full Text] [Related]

  • 9. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB.
    Eur J Nucl Med Mol Imaging; 2016 Feb 01; 43(2):259-269. PubMed ID: 26359191
    [Abstract] [Full Text] [Related]

  • 10. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z, Habibi M, Okada DR, Smith J, Derakhshan A, Zimmerman SL, Misra S, Gilotra NA, Berger RD, Calkins H, Tandri H, Chrispin J.
    Am J Cardiol; 2020 Nov 01; 134():123-129. PubMed ID: 32950203
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
    Athwal PSS, Chhikara S, Ismail MF, Ismail K, Ogugua FM, Kazmirczak F, Bawaskar PH, Elton AC, Markowitz J, von Wald L, Roukoz H, Bhargava M, Perlman D, Shenoy C.
    JAMA Cardiol; 2022 Oct 01; 7(10):1057-1066. PubMed ID: 36103165
    [Abstract] [Full Text] [Related]

  • 12. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
    Stevenson A, Bray JJH, Tregidgo L, Ahmad M, Sharma A, Ng A, Siddiqui A, Khalid AA, Hylton K, Ionescu A, Providencia R, Kirresh A.
    JACC Cardiovasc Imaging; 2023 Mar 01; 16(3):345-357. PubMed ID: 36752432
    [Abstract] [Full Text] [Related]

  • 13. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
    Trivieri MG, Robson PM, Vergani V, LaRocca G, Romero-Daza AM, Abgral R, Devesa A, Azoulay LD, Karakatsanis NA, Parikh A, Panagiota C, Palmisano A, DePalo L, Chang HL, Rothstein JH, Fayad RA, Miller MA, Fuster V, Narula J, Dweck MR, Morgenthau A, Jacobi A, Padilla M, Kovacic JC, Fayad ZA.
    JACC Cardiovasc Imaging; 2024 Apr 01; 17(4):411-424. PubMed ID: 38300202
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Localization of Late Gadolinium Enhancement and Its Association with Ventricular Tachycardia in Patients with Cardiac Sarcoidosis.
    Yodogawa K, Fukushima Y, Tachi M, Fujimoto Y, Hagiwara K, Oka E, Hayashi H, Murata H, Yamamoto T, Iwasaki YK, Amano Y, Kumita SI, Shimizu W.
    Int Heart J; 2022 Apr 01; 63(2):235-240. PubMed ID: 35354745
    [Abstract] [Full Text] [Related]

  • 17. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.
    Magnocavallo M, Vetta G, Polselli M, Cauti FM, Parlavecchio A, Caminiti R, Crea P, Pannone L, Sorgente A, Chimenti C, Chierchia GB, Rossi P, Natale A, de Asmundis C, Bianchi S, Della Rocca DG.
    J Cardiovasc Electrophysiol; 2023 Aug 01; 34(8):1781-1784. PubMed ID: 37493490
    [Abstract] [Full Text] [Related]

  • 18. Spatial dispersion analysis of LGE-CMR for prediction of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Aronis KN, Okada DR, Xie E, Daimee UA, Prakosa A, Gilotra NA, Wu KC, Trayanova N, Chrispin J.
    Pacing Clin Electrophysiol; 2021 Dec 01; 44(12):2067-2074. PubMed ID: 34766627
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.